| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.00047 | 1 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.0004 | 1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.00032 | 1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0003 | 1 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.00024 | 1 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.00016 | 1 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0002 | 1 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -9.6e-05 | 1 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -9e-05 | 1 |